Sun Pharma introduces Ilumya in India for treatment of moderate-to-severe plaque psoriasis: Our Bureau, Mumbai Tuesday, December 2, 2025, 14:45 Hrs [IST] Sun Pharma has announced ...

Mumbai-based Sun Pharma has introduced its global innovative biologic Ilumya (Tildrakizumab) in India for the treatment of moderate-to-seve.

Early indicators point toward a positive opening for Dalal Street. The GIFT Nifty, traded on the NSE IX, was higher by 130.50 ...

Accord BioPharma Inc., the specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology, immunology, and critical care therapies, announced that Express Scripts, one of ...

Researchers in China report that global incidence rates of psoriasis rose slightly from 1990 to 2021 and are projected to ...

The cost of 15 prescription drugs – including super-popular medications used for weight loss – will be lowered following ...

North America and Western Europe — two wealthier regions of the world — reported the highest incidences and are projected to ...

The list of drugs seeing a price cut for Medicare recipients is increasing — some cancer meds are set to drop by thousands.

“Our study demonstrated in a large real-world population that long-term treatment of up to 5 years with adalimumab in adult patients with psoriasis led to a sustained improvement in the practice of ...